INVO Bioscience, Inc. (INVO)

NASDAQ: INVO · IEX Real-Time Price · USD
1.160
+0.060 (5.45%)
At close: Mar 28, 2024, 9:33 AM
1.080
-0.080 (-6.90%)
After-hours: Mar 28, 2024, 4:00 PM EDT

Company Description

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide.

Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body.

INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.

INVO Bioscience, Inc.
INVO Bioscience logo
Country United States
Founded 2007
Industry Medical Devices
Sector Healthcare
Employees 15
CEO Steven M. Shum

Contact Details

Address:
5582 Broadcast Court
Sarasota, Florida 34240
United States
Phone (978) 878-9505
Website invobio.com

Stock Details

Ticker Symbol INVO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001417926
CUSIP Number 44984F302
ISIN Number US44984F4019
Employer ID 20-4036208
SIC Code 3841

Key Executives

Name Position
Steven M. Shum Chief Executive Officer and Director
Andrea Goren Chief Financial Officer
Michael Jos. Campbell Chief Operating Officer and Vice President of Business Development
Bojan Mitrovic Ph.D. Director of Sales US
Robert Joseph Bowdring Jr. Treasurer and Secretary
Terah Krigsvold Controller

Latest SEC Filings

Date Type Title
Mar 27, 2024 10-K/A [Amend] Annual report
Mar 1, 2024 8-K Current Report
Feb 6, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 1, 2024 8-K Current Report
Jan 16, 2024 S-4 Filing
Jan 10, 2024 8-K/A [Amend] Current report
Jan 10, 2024 8-K Current Report
Jan 3, 2024 8-K Current Report
Dec 28, 2023 424B7 Filing
Dec 28, 2023 8-K Current Report